The Global Binders Excipients Market was valued at USD 1.28 Billion in 2025 and is projected to reach USD 2.15 Billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period (2025–2032). This growth is driven by the surging global demand for pharmaceutical products, significant expansion in generic drug manufacturing, and the accelerating adoption of multifunctional and co-processed excipients that enhance drug performance and manufacturing efficiency.

As the pharmaceutical industry advances towards more complex and patient-centric drug designs, the foundational role of binder excipients becomes increasingly critical. These components are not just inert fillers; they are engineered materials essential for tablet integrity, stability, and bioavailability. In this blog, we profile the Top 10 Companies in the Binders Excipients Industry—a mix of global chemical giants, specialty excipient innovators, and pharmaceutical solutions leaders who are shaping the future of drug formulation.

---

🔟 1. Ashland Global Holdings Inc.

Headquarters: Wilmington, Delaware, USA
Key Offering: Klucel® (HPC), Blanose® (CMC), Benecel™ (HPMC), Aqualon™ Ethylcellulose

Ashland is a preeminent global leader in pharmaceutical excipients, renowned for its extensive portfolio of cellulose-based binders. Its products, such as hydroxypropyl cellulose (HPC) and hydroxypropyl methylcellulose (HPMC), are industry standards for controlled release, film coating, and tablet binding. Ashland serves a vast network of pharmaceutical customers with high-purity, consistent, and compliant ingredients backed by robust technical support.

Innovation Focus:

• Development of multifunctional excipient platforms
• Investment in spray-dried and co-processed excipient technologies
• Sustainability initiatives through bio-based and biodegradable polymer projects

Download FREE Sample Report:
Binders Excipients Market – View in Detailed Research Report

---

9️⃣ 2. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: Kollidon® (PVP), Kollicoat®, Lugin® (HPMC), BASF Pharma Polymers

BASF is a powerhouse in pharmaceutical solutions, offering one of the most comprehensive portfolios of synthetic and semi-synthetic binder polymers. Its Kollidon® range of polyvinylpyrrolidone (PVP) and copovidone is critical for direct compression and wet granulation. BASF’s deep R&D capabilities drive continuous innovation, recently launching novel excipients with enhanced compressibility for challenging APIs.

Innovation Focus:

• Advanced polymer science for solubility enhancement
• Tailored excipient solutions for biologics and amorphous solid dispersions
• Commitment to carbon-neutral production pathways

---

8️⃣ 3. Colorcon Inc.

Headquarters: Harleysville, Pennsylvania, USA
Key Offering: Starch 1500® (Pregelatinized Starch), Opadry® film coating systems, Surelease® (Ethylcellulose dispersion)

Colorcon is a highly specialized leader, primarily known for its film coating systems but also a critical supplier of premium binder excipients. Its Parteck® and Starch 1500® products are widely used as binders and disintegrants. The company excels in providing integrated formulation solutions, combining binders with other functional excipients to streamline pharmaceutical development.

Innovation Focus:

• Expertise in co-processed excipients for direct compression
• Development of sugar- and film-based binder systems for orally disintegrating tablets (ODTs)
• Global technical service and application laboratories

---

7️⃣ 4. Croda International Plc

Headquarters: Snaith, East Yorkshire, United Kingdom
Key Offering: Super Refined® excipients, Incromega®, and other high-purity, biocompatible ingredients.

Croda Pharma leverages its expertise in natural, sustainably sourced ingredients to provide high-performance excipients for sensitive formulations. While not a traditional binder giant, it offers critical lipid- and surfactant-based systems that function as binders and stabilizers in complex solid dispersions and for poorly soluble drugs, serving the high-value niche of advanced drug delivery.

Innovation Focus:

• Purification technologies for ultra-pure, low-peroxide excipients
• Natural, plant-derived functional ingredients for clean-label trends
• Targeted solutions for injectable and high-potency drug formulations

Download FREE Sample Report:
Binders Excipients Market – View in Detailed Research Report

---

6️⃣ 5. Dow Chemical Company

Headquarters: Midland, Michigan, USA
Key Offering: Methocel™ (HPMC), Ethocel™ (Ethylcellulose), Polyox™ (Polyethylene Oxide)

Dow is a foundational supplier of cellulosic polymers to the pharmaceutical industry. Its Methocel and Ethocel brands are ubiquitous in formulations requiring extended release, binding, and film coating. Dow’s large-scale manufacturing ensures reliable supply, and its polymers are integral to both conventional and novel dosage forms, including matrix tablets and abuse-deterrent formulations.

Innovation Focus:

• Polymer chemistry for tailored viscosity and release profiles
• Applications in 3D printing of pharmaceuticals (additive manufacturing)
• Sustainable sourcing of cellulose raw materials

---

5️⃣ 6. FMC Corporation (FMC BioPolymer)

Headquarters: Philadelphia, Pennsylvania, USA
Key Offering: Avicel® (Microcrystalline Cellulose – MCC), Aquacoat® (Cellulose-based coatings).

FMC, through its Avicel® brand, is synonymous with microcrystalline cellulose, one of the most essential dry binders and diluents in tablet manufacturing. MCC is prized for its exceptional binding and disintegration properties, making it a cornerstone of direct compression. FMC’s expertise in alginates also provides alternative binding solutions for niche applications.

Innovation Focus:

• Leadership in co-processed MCC grades (e.g., with guar gum, sodium CMC)
• Enhancing flow and compaction properties for high-speed tableting
• Applications in nutraceutical and OTC tablet markets

---

4️⃣ 7. Roquette Frères

Headquarters: Lestrem, France
Key Offering: Lycatab® (Pregelatinized Starch), Pearlitol® (Mannitol), Kleptose® (Cyclodextrins), Glucidex® (Maltodextrins)

Roquette is a global leader in plant-based ingredients, offering a vital portfolio of binder excipients derived from starch and sugar. Its Lycatab® pregelatinized starch is a natural, cost-effective binder and disintegrant. Roquette’s strength lies in providing biocompatible, non-GMO, and allergen-free excipients, aligning with the demand for clean-label and patient-friendly formulations.

Innovation Focus:

• Innovation in excipients for orally disintegrating tablets (ODTs) and chewables
• Development of multifunctional fillers-binders like mannitol-starch combinations
• Expansion of capacity to meet global pharmaceutical demand

---

3️⃣ 8. Merck KGaA (EMD Millipore in the US & Canada)

Headquarters: Darmstadt, Germany
Key Offering: Parteck® excipients (e.g., Parteck® M D-Mannitol), Ludi® sweeteners and binders.

Merck KGaA’s Life Science business is a key player in high-purity pharmaceutical excipients. Its offerings include innovative binder systems like mannitol-based excipients designed for direct compression and ODT formulations. The company provides end-to-end solutions, from raw materials to final drug product testing, emphasizing quality and supply chain security.

Innovation Focus:

• Engineered particle technology for superior tableting performance
• Excipients tailored for challenging APIs and biologics formulation
• Digital tools and services for formulation development support

---

2️⃣ 9. Ingredion Incorporated

Headquarters: Westchester, Illinois, USA
Key Offering: Purity Gum® starches, Instant Pure-Cote® starches, and other modified food starches adapted for pharmaceutical use.

Ingredion is a major global supplier of specialty starches, many of which serve as effective and economical binders in pharmaceutical tablets and capsules. Its expertise in starch modification allows it to produce excipients with consistent functionality, acting as binders, disintegrants, and film formers, particularly in nutraceutical and generic drug markets.

Innovation Focus:

• Clean-label, non-GMO, and organic-certified starch-based binders
• Co-processing starch with other functional ingredients
• Supporting the growth of the global herbal and traditional medicine sectors

---

1️⃣ 10. DFE Pharma

Headquarters: Goch, Germany
Key Offering: Pharmacel® (MCC), Vivapur® (MCC), Lactose, Starch, and co-processed excipient blends.

DFE Pharma is a world-leading, fully dedicated pharmaceutical excipient company formed from the joint venture of FrieslandCampina and Fonterra. It is a top supplier of core binder/diluents like microcrystalline cellulose and lactose. DFE Pharma focuses exclusively on excipients, offering deep application knowledge, high-quality products, and reliable global supply to the pharmaceutical industry.

Innovation Focus:

• Specialized grades of MCC and lactose for high-dose and pediatric formulations
• Development of ready-to-use, multifunctional excipient blends to simplify formulation
• Expertise in dry powder inhaler (DPI) carrier excipients, a related binding function

Get Full Report Here:
Binders Excipients Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Binders Excipients Is Functional and Patient-Centric

The binders excipients market is undergoing a significant evolution. While traditional commodity binders remain essential, the industry is strategically investing in advanced functional materials, co-processing technologies, and excipients that enable next-generation drug delivery.

📈 Key Trends Shaping the Market:

• Rapid adoption of co-processed and multifunctional excipients to reduce formulation complexity
• Increased demand for binders compatible with challenging APIs (poorly soluble, high-potency, biologic)
• Regulatory emphasis on Quality by Design (QbD) driving the need for highly characterized, consistent excipients
• Growth of personalized medicine and specialized dosage forms (ODTs, minitablets) requiring novel binder solutions

Get Full Report Here:
Binders Excipients Market – View in Detailed Research Report

The companies listed above are not only supplying essential formulation ingredients—they are enabling the innovation and reliability of modern pharmaceutical therapies, ensuring medicines are effective, stable, and accessible worldwide.